Baird upgrades Alcon after strong Q1 earnings, shares rise 7%
Alcon reports strong Q1 earnings, beats consensus estimates Swiss-based eye care company Alcon reported strong Q1 earnings that beat consensus estimates, leading to a surge in its stock price. Investment firm Baird upgraded its rating on the company’s stock from Neutral to Outperform and raised its price target from $75.